For the year ending 2025-12-31, PIII made $1,459,080K in revenue. -$147,948K in net income. Net profit margin of -10.14%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total operating revenue | 1,459,080 | 1,500,455 | ||
| Medical expense | 1,519,240 | 1,559,372 | ||
| Premium deficiency reserve | 18,749 | 53,698 | ||
| Corporate, general and administrative expense | 106,311 | 112,596 | ||
| Sales and marketing expense | 918 | 1,331 | ||
| Depreciation and amortization | 84,163 | 86,058 | ||
| Impairment of assets held for sale | 0 | 8,058 | ||
| Total operating expense | 1,729,381 | 1,821,113 | ||
| Operating loss | -270,301 | -320,658 | ||
| Interest expense, net | -55,034 | -22,173 | ||
| Mark-to-market of stock warrants | -7,850 | -22,114 | ||
| Gain (loss) on disposition of assets | -162 | 13,269 | ||
| Other | -3,414 | 1,457 | ||
| Total other income (expense) | -50,760 | 14,667 | ||
| Loss before income taxes | -321,061 | -305,991 | ||
| Income tax provision | 2,025 | 4,387 | ||
| Net loss | -323,086 | -310,378 | ||
| Less net loss attributable to redeemable non-controlling interest | -175,138 | -174,529 | ||
| Net loss attributable to controlling interest | -147,948 | -135,849 | ||
| Basic EPS | -45.26 | -0.94 | ||
| Diluted EPS | -45.26 | -1.08 | ||
| Basic Average Shares | 3,269,000 | 145,175,000 | ||
| Diluted Average Shares | 3,269,000 | 146,998,000 | ||
P3 Health Partners Inc. (PIII)
P3 Health Partners Inc. (PIII)